Smoking and 2-month culture conversion during anti-tuberculosis treatment.

OBJECTIVE To investigate risk factors for delayed sputum culture conversion to negative during anti-tuberculosis treatment, with an emphasis on smoking. DESIGN Nested case-control study of adults with non-cavitary, culture-confirmed pulmonary tuberculosis (TB) participating in an anti-tuberculosis treatment trial in Brazil. A case of delayed culture conversion was a patient who remained culture-positive after 2 months of treatment. Odds ratios with 95% confidence intervals were calculated. RESULTS Fifty-three cases and 240 control patients were analyzed. Smokers had three-fold greater odds of remaining culture-positive after 2 months of treatment (P = 0.007) than non-smokers, while smokers and ex-smokers who smoked >20 cigarettes a day had two-fold greater odds of remaining culture-positive after 2 months of treatment (P = 0.045). CONCLUSION Cigarette smoking adversely affects culture conversion during anti-tuberculosis treatment. Support for smoking cessation should be considered to improve outcomes in TB control programs.

[1]  John L. Johnson,et al.  Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion. , 2009, American journal of respiratory and critical care medicine.

[2]  Jian-ming Wang,et al.  Review of cigarette smoking and tuberculosis in China: intervention is needed for smoking cessation among tuberculosis patients , 2009, BMC public health.

[3]  John L. Johnson,et al.  Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis. , 2008, American journal of respiratory and critical care medicine.

[4]  L. Rodrigues,et al.  Smoking increases the risk of relapse after successful tuberculosis treatment , 2008, International journal of epidemiology.

[5]  J. Blanco,et al.  Tabaquismo y negativización bacteriológica del esputo en la tuberculosis pulmonar , 2007 .

[6]  J. A. Gullón Blanco,et al.  [Tobacco smoking and sputum smear conversion in pulmonary tuberculosis]. , 2007, Medicina clínica (Ed. impresa).

[7]  K. Dheda,et al.  Smoking and tuberculosis: the epidemiological association and immunopathogenesis. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  B. Jayakrishnan,et al.  Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis. , 2005, Respiratory medicine.

[9]  N. Khan,et al.  Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  Alimuddin Zumla,et al.  Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial , 1999, The Lancet.

[11]  J. Justman,et al.  Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  D. Mitchison.  Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. , 1993, The American review of respiratory disease.

[13]  Lloyd N. Friedman,et al.  Diagnostic standards and classification of tuberculosis. , 1991, The American review of respiratory disease.

[14]  B. Graovac.  [Classification of pulmonary tuberculosis]. , 1956, Tuberkuloza.